<DOC>
	<DOCNO>NCT01384903</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety KW-3357 compare plasma-derived antithrombin use multi-center , open-label , parallel-group , comparative method patient Disseminated Intravascular Coagulation ( DIC ) associate infection .</brief_summary>
	<brief_title>An Open-label Study KW-3357</brief_title>
	<detailed_description />
	<mesh_term>Disseminated Intravascular Coagulation</mesh_term>
	<mesh_term>Antithrombins</mesh_term>
	<mesh_term>Antithrombin III</mesh_term>
	<criteria>Meet ACCP/SCCMdefined sepsis criterion Japanese Association Acute Medicinedefined DIC criterion score &gt; = 4 Antithrombin activity &lt; = 70 % Written informed consent patient guardian Anamnesis complication serious drug allergy Serious liver disorder , fulminant hepatitis decompensated cirrhosis Pregnant , nursing , possibly pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>